Jump to content

Dusigitumab

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DePiep (talk | contribs) at 15:16, 28 February 2016 (molar weight unit in g/mol (via AWB script)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Dusigitumab
Monoclonal antibody
Type?
SourceHuman
TargetILGF2
Clinical data
ATC code
  • none
Identifiers
CAS Number
IUPHAR/BPS
ChemSpider
  • none
Chemical and physical data
FormulaC6372H9824N1700O2016S54
Molar mass151 kg/mol g·mol−1

Dusigitumab is a human monoclonal antibody designed for the treatment of cancer. It binds to IGLF2.[1]

This drug was developed by MedImmune, LLC.

References